Professional
Added to YB: 2024-02-22
Pitch date: 2024-02-22
BLCO [bullish]
Bausch + Lomb Corporation
-1.1%
current return
Author Info
No bio for this author
Company Info
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally.
Market Cap
$5.5B
Pitch Price
$17.28
Price Target
26.00 (+53%)
Dividend
N/A
EV/EBITDA
17.06
P/E
-18.07
EV/Sales
2.06
Sector
Health Care Equipment and Supplies
Category
growth
Bausch + Lomb Corporation: We Think 2024 Will Be a Year of Innovation and Growth
BLCO $26 FV: Narrow-moat vision care co. Strong Q4 '23, '24 growth potential. Vision care +17.8% YoY, contacts +LSD. OTC eye drops leader, expanding to chronic condition Rx. Daily SiHy lenses +31%, higher price & margin. Ophthalmic Rx +66.8%, M&A to drive '24 margins. Surgical 19% of sales, growth expected. Risks: patent expirations, high debt, macro.
Read full article (14 min)